US20050136143A1 - Athermal process for the concentration of Garcinia extract - Google Patents

Athermal process for the concentration of Garcinia extract Download PDF

Info

Publication number
US20050136143A1
US20050136143A1 US10/743,278 US74327803A US2005136143A1 US 20050136143 A1 US20050136143 A1 US 20050136143A1 US 74327803 A US74327803 A US 74327803A US 2005136143 A1 US2005136143 A1 US 2005136143A1
Authority
US
United States
Prior art keywords
extract
membrane
garcinia
osmotic
hca
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/743,278
Inventor
Chinnaswamy Ramakrishnan
Naveen Nagaraj
Guddadarangavvanahally Jayaprakasha
Bhabani Jena
Mandyam Varadaraj
Karumanchi Mallikarjuna Srinivasa Raghavarao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Priority to US10/743,278 priority Critical patent/US20050136143A1/en
Assigned to COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH reassignment COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: JAYAPRAKASHA, GUDDADARANGAVVANAHALLY KRISHNAREDDY, JENA, BHABANI SANKAR, RAGHAVARAO, KARUMANCHI SREESAILA MALLIKARJUNA SRINIVASA, VARADARAJ, MANDYAM CHAKRAVARATHY, NAGARAJ, NAVEEN, RAMAKRISHNAN, CHINNASWAMY ANANDHA
Publication of US20050136143A1 publication Critical patent/US20050136143A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/38Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis, ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/36Pervaporation; Membrane distillation; Liquid permeation
    • B01D61/364Membrane distillation

Abstract

The present invention relates to an athermal process of obtaining concentrated Garcinia extract by using osmotic membrane distillation (OMD).

Description

    FIELD OF THE INVENTION
  • The present invention relates to an athermal process for the concentration of Garcinia extract. The present invention particularly relates to a process of obtaining concentrated Garcinia extract by using osmotic membrane distillation (OMD).
  • BACKGROUND OF THE INVENTION
  • As dietary supplement, (−)-Hydroxcitic acid (HCA) is an effective agent to any weight management program. Allison et al. (Crit.Rev.Food Sci.Nutr. 2001, 41,1-28) has reviewed the use of HCA as one of the alternative treatments for weight loss. The derivatives of HCA have been incorporated into many pharmaceutical preparations in combination with other ingredients for the purpose of enhancing weight loss, cardioprotection, correcting the conditions of lipid abnormalities and endurance(Jena et al., 2002, J. Agric. Food Chemistry, 50,10-22). So far HCA has been found in the fruits of certain species of Garcinia, which includes G. cambogia, G. indica, G.atroviridis and G. cowa (Lewis, Y. S. 1969, Methods in enzymology, 13, 613-623; Jena et al., 2002, J. Agric. Food Chemistry, 50,10-22). The chemistry and biochemistry of HCA has been discussed recently (Jena et al., 2002, J. Agric. Food Chemistry, 50,10-22). During extensive animal studies, HCA has been proven to effectively curb appetite, suppress food intake, increase the rates of hepatic glycogen synthesis, reduce fatty acid synthesis and lipogenesis and decrease body-weight gain. Garcinia (Family: Guttiferae) is a large genus of polygamous trees or shrubs, distributed in the tropical Asia, Africa and Polynesia. It consists of 180 species, out of which about 30 species are found in India. G. pedunculata and G. cowa are grown in Northeastern parts of India and Andaman Islands. In Assam G. cowa is often cultivated in homesteads for its acid fruits (The Wealth of India, 1956). The fruits from both the species of Garcinia are not palatable due to their strong acid taste. In Assam the sun dried slices of the fruits are used for culinary purposes and as folk medicine.
  • Reference may be made to the commercial samples of Garcinia cambogia extracts, where the HCA is present as its calcium salt (Sawada, et al, 1997, Nihon yukagaka kaishi, vol,1467-1474). But the excess calcium reduces the solubility and subsequently bioavailability when it is compared to the liquid extract.
  • Another reference may be made to the Ashok kumar., Ravindranath, B., and Balasubramamanvam (U.S. Pat. No. 656,314, 1996). This process involves water extraction, followed by passing through ion exchange resins and decolorisation by using activated charcoal and finally concentration by using vacuum evaporation. The main drawback of this method is the thermal process and also it involves too many unit operations for obtaining the final product.
  • Reference may be made to Majeed et al. (Majeed, M., Badmaev, V and Rajendran, R. U.S. Pat. No. 5,783,603, 1998), wherein the preparation of potassium hydroxycitrate from Garcinia fruit was reported. It involves the extraction of Garcinia fruit using alkyl alcohol, the extract was treated with potassium hydroxide and refluxed to form potassium hydroxycitrate precipitate. The main drawback of this method is the potassium salt is hygroscopic. Further, HCA is not available in natural state, limiting its bioavailability and versatile applicability for pharmaceutical purposes.
  • It may be noted that all these references are mentioned above HCA derivatives preparations. But, there is no report on non-thermal process for concentrating of HCA and also in its native (not as derivatives) form.
  • OBJECTS OF THE INVENTION
  • The main object of the present invention is to develop a process for the concentrated Garcinia extract from G. pedunculata/G.cowa in liquid form.
  • Another object of present invention is to develop a non-thermal process for the concentration of Garcinia extract.
  • Still another object of the present invention is to develop a process for the concentrating of Garcinia extract using osmotic membrane distillation (OMD).
  • Yet another object of present invention is to provide a simple single step and efficient economical process for the concentration of HCA, wher it is present in its native form.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Accordingly, the present invention provides an athermal process for the concentrating of Garcinia extract, which comprises
      • (a) collecting the dried fruit rinds may be effected from the species of Garcinia.
      • (b) cutting the rinds of G. pedunculata/G.cowa manually to a size of 3×9 mm to 6×14 mm.
      • (c) extracting may be effected with de-ionized water at a volume ratio of 1:4 for a period of 15-35 min at 110-130° C.
      • (d) filtering the above extract may be effected by filter cloth.
      • (e) concentrating the HCA by osmotic membrane distillation (OMD) in a co-current flat membrane module.
      • (f) placing a hydrophobic membrane between two steel frames SS316 of the module with suitable spaces.
      • (g) circulating the extract at a flow rate of 100-150 ml/min on the one side of the membrane using a multi-stage peristaltic pump.
      • (h) hydrophobic membrane osmotic agent (OA) on the other side of the membrane using a multi-stage peristaltic pump.
      • (i) carrying out OMD for about 4-6 hrs till the extract was concentrated in the feed tank.
  • In an embodiment of the present invention, the HCA concentration may be obtained from the aqueous extract of G. pedunculata and G.cowa.
  • In an another embodiment of the present invention, concentrated Garcinia extract may be obtained by using an athermal membrane process namely, Osmotic membrane distillation (OMD) at ambient temperature (25±1° C.) and pressure (1 atm).
  • Still another embodiment of present invention, the HCA content of the concentrated Garcinia extract is in the range of 33-37% estimated by HPLC method.
  • Yet in another embodiment of present invention the Garcinia extract was concentrated by a simple single step process where the HCA content was increased from 4-6 fold and HCA is present in the native form (not as derivative) with out formation of lactone, increasing it commercial and nutritive values.
  • In the present invention, rinds of G. pedunculata/G.cowa were cut into small pieces and extracted with de-ionized water. The above extract was filtered through filter cloth. Concentrating the HCA by osmotic membrane distillation in a co-current flat membrane module. The membrane module consisted of two steel frames SS316 between which a hydrophobic membrane was placed. The entire filtrate was circulated on the one side of the OMD membrane and on the other side, an osmotic agent (OA) was circulated using a multi-stage peristaltic pump. After desired time the extract was concentrated in the feed tank.
  • The purity of the preparation was analyzed by HPLC as described by Jayaprakasha, G. K. and Sakariah, K. K. (J. Liquid Chromatography & Related Technologies, 23, 915-923, 2000). Concentrated hydroxycitric acid (0.1 g) was dissolved in water and made up to 100 ml with water and filtered. The high performance liquid chromatographic system consisted of a Hewlett Packard HPLC model HP 1100 Series (Hewlett-Packard, Calif., USA), fitted with a Waters μ-Bondapack™ (Waters Corporation, Milford, Mass., USA) C18 column (250×4.6 mm I.D). The injection system (Rheodyne) used was 20 μl sample loop. Detection was done by a HP 1100 series variable wavelength detector at wavelength of 210 nm. The elution was carried out with 8 mM sulphuric acid and flow rate was 1.0 ml/min under isocratic condition. A known volume (10 μl) of the samples was injected on to the HPLC and the concentration of HCA was obtained directly from the peak area and by application of the dilution factor. The HCA concentration of the sample was expressed as g/100 g of sample. The purity of hydroxycitric acid was 33-35% (w/w).
  • The important aspects of the invention are:
      • 1. Concentrated Garcinia extract is obtained by athermal membrane process.
      • 2. This is a single step process for obtaining the concentrated Garcinia extract.
      • 3. In the present process there is no phase change.
      • 4. This process is operated at ambient temperature and pressure so that no thermal damage of the product.
      • 5. HCA content was increased from 4-6 fold.
      • 4. There is no lactone formation during this process.
  • The following examples are given by way of illustration of the present invention and should not be construed to limit the scope of the present invention.
  • EXAMPLE-1
  • Fruit rinds of G. pedunculata in 500 g quantity were cut into small pieces and extracted with 1.5 liters of de-ionized water for a period of 20 min at 120° C. The above extract was filtered through filter cloth. The extract was taken and subjected to concentration by osmotic membrane distillation in a co-current flat membrane module using micro porous hydrophobic polypropylene membrane of 0.05 μm at a flow rate of 100 ml/min. The module was operated in co-current mode using saturated calcium chloride as osmotic agent. The concentration was carried out till the volume of the extract was reduced to ⅕ of the original volume. The concentration of HCA had increased from 6 to 62° Brix. The HCA content was determined by HPLC method and the acid was found to be 33.58% from an initial content of 5.09%. (6 fold enhancement).
  • EXAMPLE-2
  • Fruit rinds of G. cowa in 1000 g quantity were cut into small pieces and extracted with 3 liters of de-ionized water for a period of 30 min at 130 psi using autoclaving. The extract was filtered through filter cloth. The extract was taken and subjected to concentration by osmotic membrane distillation in a co-current flat membrane module using micro porous hydrophobic polypropylene membrane of 0.05 μm at a flow rate of 130 ml/min. The module was operated in co-current mode using saturated calcium chloride as osmotic agent. The concentration was carried out till the volume of the extract was reduced to {fraction (1/5)}th of the original volume. The concentration of HCA had increased from 6 to 62° Brix. The HCA content was determined by HPLC method and the acid was found to be 35.5% from an initial content of 6%. (7 fold enhancement).
  • EXAMPLE-3
  • Fruit rinds of G. pedunculata in 100 gm quantity were cut into small pieces and extracting with 1 liter of de-ionized water for a period of 50 min at 120° C. using autoclaving. The extract was filtered through filter cloth. The extract was taken and subjected to concentration by osmotic membrane distillation in a co-current flat membrane module using micro porous hydrophobic polypropylene membrane of 0.05 μm at a flow rate of 150 ml/min. The module was operated in co-current mode using saturated calcium chloride as osmotic agent. The concentration was carried out till the volume of the extract was reduced to ⅕th of the original volume. The concentration of HCA had increased from 6 to 62° Brix. The HCA content was determined by HPLC method and the acid was found to be 34.5% from an initial content of 5%. (6 fold enhancement).
  • The main advantages of the present invention are
      • 1. This is a simple and single step process for obtaining the concentrated free HCA.
      • 2. This concentrated Garcinia extract is in its native form without being any of its derivatives like sodium, potassium and calcium salts. Hence it will have better bioavailability.
      • 3. This product does not undergo any thermal damage since the process is athermal, therby the product is suitable for food/therapeutic applications.
      • 4. This process is simpler and easy to scale-up.

Claims (11)

1. An athermal process for the concentrating Garcinia extract, which comprises
a) collecting and cutting dried rinds of a fruit selected from Garcinia sp, G. pedunculata and G.cowa,
b) extracting the cut rinds with de-ionized water at a volume ratio of 1:4 for a period of 20-30 min at 115° C.-130° C. to obtain an extract,
c) filtering the extract to obtain a particle free extract, and
d) subjecting the particle free extract to osmotic membrane distillation in a co-current mode in the presence of an osmotic agent until the extract reduced to ⅕th of its original volume.
2. A process as claimed in claim 1 further comprising the step of obtaining hydrocitric acid from the concentrated extract of step (d).
3. A process as claimed in claim 1 wherein a hydrophobic membrane is placed between two steel frames SS316 of the module with suitable spaces.
4. A process as claimed in claim 1 wherein the extract is circulated at a flow rate of 100-150 ml/min on one side of the membrane using a multi-stage peristaltic pump.
5. A process as claimed in claim 1 wherein a hydrophobic membrane osmotic agent (OA) is placed on the other side of the membrane using a multi-stage peristaltic pump.
6. A process as claimed in claim 1 wherein the osmotic agent is saturated calcium chloride.
7. A process as claimed in claim 1 wherein the osmotic membrane distillation is carried out at ambient temperature of 25±1° C. and pressure of 1 atm.
8. A process as claimed in claim 1 wherein the osmotic membrane distillation is carried on for about 4-6 hrs till the extract was concentrated in the feed tank.
9. A process as claimed in claim 1 wherein the free hydrocitric acid content in the concentrate is in the range 33-35% estimated by HPLC method.
10. A process as claimed in claim 1 wherein the hydrocitric acid content was increased from 4-6 fold and HCA is present in the native form (not as derivative) with out formation of lactone, increasing it commercial and nutritive values.
11. An athermal process for the concentration of Garcinia extract comprising the steps of:
a) collecting the dried fruit rinds may be effected from the species of Garcinia
b) cutting the rinds of G. pedunculata/G.cowa manually to a size of 3×9 mm to 6×14 mm
c) extracting may be effected with de-ionized water at a volume ratio of 1:4 for a period of 15-35 min at 110-130° C.
d) filtering the above extract may be effected by filter cloth
e) concentrating the HCA by osmotic membrane distillation (OMD) in a co-current flat membrane module
f) placing a hydrophobic membrane between two steel frames SS316 of the module with suitable spaces
g) circulating the extract at a flow rate of 100-150 ml/min on the one side of the membrane using a multi-stage peristaltic pump
h) hydrophobic membrane osmotic agent (OA) on the other side of the membrane using a multi-stage peristaltic pump
i) carrying out OMD for about 4-6 hrs till the extract was concentrated in the feed tank.
US10/743,278 2003-12-22 2003-12-22 Athermal process for the concentration of Garcinia extract Abandoned US20050136143A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/743,278 US20050136143A1 (en) 2003-12-22 2003-12-22 Athermal process for the concentration of Garcinia extract

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/743,278 US20050136143A1 (en) 2003-12-22 2003-12-22 Athermal process for the concentration of Garcinia extract
US11/509,831 US7431951B2 (en) 2003-12-22 2006-08-24 Athermal process for the concentration of Garcinia extract

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/509,831 Continuation US7431951B2 (en) 2003-12-22 2006-08-24 Athermal process for the concentration of Garcinia extract

Publications (1)

Publication Number Publication Date
US20050136143A1 true US20050136143A1 (en) 2005-06-23

Family

ID=34678628

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/743,278 Abandoned US20050136143A1 (en) 2003-12-22 2003-12-22 Athermal process for the concentration of Garcinia extract
US11/509,831 Expired - Fee Related US7431951B2 (en) 2003-12-22 2006-08-24 Athermal process for the concentration of Garcinia extract

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/509,831 Expired - Fee Related US7431951B2 (en) 2003-12-22 2006-08-24 Athermal process for the concentration of Garcinia extract

Country Status (1)

Country Link
US (2) US20050136143A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536516A (en) * 1994-08-24 1996-07-16 Renaissance Herbs, Inc. Hydroxycitric acid concentrate and food products prepared therefrom
US6299777B1 (en) * 1999-08-17 2001-10-09 Cms Technology Holdings, Inc. Osmotic distillation process

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972357A (en) * 1996-12-19 1999-10-26 Kikkoman Corporation Healthy foods and cosmetics

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536516A (en) * 1994-08-24 1996-07-16 Renaissance Herbs, Inc. Hydroxycitric acid concentrate and food products prepared therefrom
US6299777B1 (en) * 1999-08-17 2001-10-09 Cms Technology Holdings, Inc. Osmotic distillation process

Also Published As

Publication number Publication date
US7431951B2 (en) 2008-10-07
US20070154578A1 (en) 2007-07-05

Similar Documents

Publication Publication Date Title
JP6141912B2 (en) Bioactive ingredient containing no parthenolide from feverfew (tanacetamparthenium) and method for producing the same
JP5324084B2 (en) Cowberry extract and its production method and use
EP1536810B1 (en) Extraction of pharmaceutically active cannabinoids from plant materials
AU2007212831B2 (en) Near-critical fluid fractionation process
JP2725889B2 (en) Separation of sugar from juices
KR100390036B1 (en) Hydroxycitric Acid Concentrate And Its Manufacturing Method
US5484594A (en) Process for preparing grapeseed extracts enriched in procyanidol oligomers
Galaverna et al. A new integrated membrane process for the production of concentrated blood orange juice: Effect on bioactive compounds and antioxidant activity
US5968517A (en) Process for extraction of proanthocyanidins from botanical material
DE69730420T2 (en) Antitumorous substance extracts from grifola frondosa
JP2009531162A (en) Extracts and methods containing green tea seeds
US20070014912A1 (en) Extraction of phytochemicals
Conidi et al. Valorization of artichoke wastewaters by integrated membrane process
CA1235594A (en) Anti-oxidant protection of foodstuffs and cosmetics
CN103524596B (en) Antioxidative peptide of shark protein as well as preparation method and use thereof
US3963700A (en) Recovery of anthocyanin from plant sources
JP4852151B2 (en) Biological lycopene-based dietary supplements and methods for obtaining biological lycopene
CN103865651A (en) Preparation method of melon and fruit perfume for cigarettes
CN1628535A (en) Packaged beverages
US20090035432A1 (en) Process for Producing a Proanthocyanidin Extract
BRPI0708826A2 (en) Extracts and methods comprising cinnamon species
CN103607882B (en) Derive from functional raw-material method for making technology and the functional components of ice plant
CN105166198A (en) Preparation method of high-purity rubusoside
CN101912480A (en) Method for preparing procyanidin extract of lycium ruthenicum murr
US20060177525A1 (en) Process for producing proanthocyanin-rich material

Legal Events

Date Code Title Description
AS Assignment

Owner name: COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH, IND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RAMAKRISHNAN, CHINNASWAMY ANANDHA;NAGARAJ, NAVEEN;JAYAPRAKASHA, GUDDADARANGAVVANAHALLY KRISHNAREDDY;AND OTHERS;REEL/FRAME:015617/0814;SIGNING DATES FROM 20040507 TO 20040707

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION